Modifiable Risk Factors and Residual Risk Following Coronary RevascularizationTrevor Simard, Benjamin Hibbert, Amos Levi et al.|Mayo Clinic Proceedings Innovations Quality & Outcomes|2021Cited by 14
Plasminogen Activator Inhibitor-1–Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC PhenotypeRichard G. Jung, Benjamin Hibbert, Anne‐Claire Duchez et al.|JACC Basic to Translational Science|2022Cited by 11
Evaluation of plasminogen activator inhibitor-1 as a biomarker of unplanned revascularization and major adverse cardiac events in coronary angiography and percutaneous coronary interventionRichard G. Jung, Benjamin Hibbert, Trevor Simard et al.|Thrombosis Research|2020Cited by 10
Performance of Plasma Adenosine as a Biomarker for Predicting Cardiovascular RiskTrevor Simard, Benjamin Hibbert, Richard G. Jung et al.|Clinical and Translational Science|2020Cited by 10
Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysisTrevor Simard, Benjamin Hibbert, Pouya Motazedian et al.|Journal of Cardiovascular Pharmacology|2021Cited by 2